Bombay High Court pulls up FDA over revocation of Pune drug firm’s licence
The Bombay High Court criticized the FDA for revoking a Pune-based drug firm's license without following proper legal procedures, including failing to hold a hearing. The FDA agreed to withdraw the order and issue a fresh notice.
Why it matters
It underscores the importance of due process and natural justice in administrative actions taken by government regulatory bodies.
The Bombay High Court on Saturday (August 29, 2026) took exception to the procedure followed by the Food and Drug Administration (FDA) in revoking the drug sale licence of a Pune-based company.
The report focuses on the legal proceedings and the court's observation of procedural failure, maintaining a neutral tone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in